Goldman Sachs’s Athenahealth, Inc. ATHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-350,030
| Closed | -$46.2M | – | 5645 |
|
|
2018
Q4 | $46.2M | Buy |
350,030
+88,377
| +34% | +$11.3M | 0.01% | 1145 |
|
|
2018
Q3 | $35M | Sell |
261,653
-956
| -0.4% | -$143K | 0.01% | 1481 |
|
|
2018
Q2 | $41.8M | Sell |
262,609
-242,279
| -48% | -$35.9M | 0.01% | 1343 |
|
|
2018
Q1 | $72.2M | Sell |
504,888
-46,827
| -8% | -$6.4M | 0.02% | 972 |
|
|
2017
Q4 | $73.4M | Sell |
551,715
-61,623
| -10% | -$7.88M | 0.02% | 999 |
|
|
2017
Q3 | $76.3M | Sell |
613,338
-22,241
| -3% | -$3.06M | 0.02% | 982 |
|
|
2017
Q2 | $89.3M | Buy |
635,579
+200,847
| +46% | +$25.1M | 0.02% | 836 |
|
|
2017
Q1 | $49M | Buy |
434,732
+234,567
| +117% | +$27.3M | 0.01% | 1234 |
|
|
2016
Q4 | $21.1M | Buy |
200,165
+110,639
| +124% | +$11.9M | 0.01% | 1927 |
|
|
2016
Q3 | $11.3M | Buy |
89,526
+47,395
| +112% | +$6.03M | ﹤0.01% | 2353 |
|
|
2016
Q2 | $5.81M | Sell |
42,131
-23,195
| -36% | -$3.07M | ﹤0.01% | 2733 |
|
|
2016
Q1 | $9.07M | Buy |
65,326
+39,477
| +153% | +$5.41M | ﹤0.01% | 2296 |
|
|
2015
Q4 | $4.16M | Sell |
25,849
-9,436
| -27% | -$1.46M | ﹤0.01% | 3002 |
|
|
2015
Q3 | $4.71M | Buy |
35,285
+9,340
| +36% | +$1.22M | ﹤0.01% | 2939 |
|
|
2015
Q2 | $2.97M | Buy |
25,945
+7,265
| +39% | +$869K | ﹤0.01% | 3444 |
|
|
2015
Q1 | $2.23M | Sell |
18,680
-3,494
| -16% | -$466K | ﹤0.01% | 3676 |
|
|
2014
Q4 | $3.23M | Buy |
22,174
+2,306
| +12% | +$290K | ﹤0.01% | 3386 |
|
|
2014
Q3 | $2.62M | Sell |
19,868
-6,767
| -25% | -$891K | ﹤0.01% | 3669 |
|
|
2014
Q2 | $3.33M | Buy |
26,635
+9,781
| +58% | +$1.26M | ﹤0.01% | 3454 |
|
|
2014
Q1 | $2.7M | Buy |
16,854
+9,096
| +117% | +$1.5M | ﹤0.01% | 3681 |
|
|
2013
Q4 | $1.04M | Sell |
7,758
-11,190
| -59% | -$1.44M | ﹤0.01% | 4712 |
|
|
2013
Q3 | $2.06M | Sell |
18,948
-26,415
| -58% | -$2.86M | ﹤0.01% | 3891 |
|
|
2013
Q2 | $3.84M | Buy |
+45,363
| New | +$4.06M | ﹤0.01% | 3014 |
|
Goldman Sachs's ATHN Position: Q1 2019 in Review
Goldman Sachs sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 350,030 shares — an estimated $46.2M sold.
Goldman Sachs first reported a position in ATHN in Q2 2013 and held it in 23 quarters. The position peaked at $89.3M in Q2 2017. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.
- Goldman Sachs reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
- Goldman Sachs sold 350,030 Athenahealth, Inc. shares in Q1 2019, an estimated $46.2M.
- Goldman Sachs first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 23 quarters.
- Goldman Sachs's Athenahealth, Inc. position peaked at $89.3M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.
Based on Goldman Sachs's 13F filing for Q1 2019, filed 15 May 2019.